Roblox RegisterIndependent record of Roblox groups · not affiliated with Roblox Corporation
Defeat The Virus Roleplay [BETA]

Defeat The Virus Roleplay [BETA]

A Roblox experience owned by Special Containment Procedures Foundation|[SCPF].

RoleplayENpandemicroleplaysimulation

Description (written by the developer; not a statement by this register)

JOIN THE GROUP FOR SPECIAL PERKS INGAME! 👨‍💻🦠 Earn points and play with your friends as you climb up the leaderboards in the fight against the viral pandemic! 👨‍🔬🔬The Plague Containment Agency is combatting the spread of deadly viruses through state-of-the-art technology and methods. Join us in defeating this virus today. This game is updated frequently so check back often! BUY A RANK HERE: Coming Soon! 𝗧𝗵𝗲 𝗴𝗼𝗮𝗹 𝗼𝗳 𝘁𝗵𝗶𝘀 𝗴𝗮𝗺𝗲 𝗶𝘀 𝗻𝗼𝘁 𝘁𝗼 𝘁𝗮𝗸𝗲 𝗮𝗱𝘃𝗮𝗻𝘁𝗮𝗴𝗲 𝗼𝗳 𝘁𝗵𝗲 𝗽𝗮𝗻𝗱𝗲𝗺𝗶𝗰, 𝗯𝘂𝘁 𝘁𝗼 𝘀𝗵𝗼𝘄 𝗵𝗼𝘄 𝘀𝗲𝗿𝗶𝗼𝘂𝘀𝗹𝘆 𝗶𝘁 𝗻𝗲𝗲𝗱𝘀 𝘁𝗼 𝗯𝗲 𝘁𝗮𝗸𝗲𝗻! 𝗧𝗵𝗶𝘀 𝗴𝗮𝗺𝗲 𝘂𝘀𝗲𝘀 𝗿𝗲𝗮𝗹-𝗹𝗶𝗳𝗲 𝗱𝗮𝘁𝗮 𝘁𝗼 𝘀𝗵𝗼𝘄 𝘁𝗵𝗲 𝗻𝗲𝗲𝗱 𝗳𝗼𝗿 𝗿𝗲𝗮𝗹-𝗹𝗶𝗳𝗲 𝗽𝗿𝗲𝘃𝗲𝗻𝘁𝗶𝘃𝗲 𝗺𝗲𝗮𝘀𝘂𝗿𝗲𝘀.

Last updated by the developer 30 Jan 2021, 02:53 UTC.

0
playing (measured 24 Aug 2026, 20:36 UTC)
262
lifetime visits
80%
liked (4 👍 / 1 👎)
4
favourites (15.3 per 1k visits)
24 January 2021
created (per Roblox)

Play on Roblox →

Live players over time

Growth

Growth history is still building. We hold one measurement for this entry. A trend needs at least two, taken days apart — so this will fill in on its own rather than being estimated. We do not publish numbers we have not measured.

Measurement log — every players count we have recorded
Measured (UTC)PlayersChange
24 Aug 2026, 20:360first reading

Concurrent players at each of our measurements (insert-on-change).

Monetization — game passes

Director Role
2,999 R$
Senator Role
1,000 R$
Infected Role
750 R$
Scientist Role
700 R$
Guard Role
685 R$
All-Level Access Card
450 R$
Approval Immunity
340 R$
Unlimited Cleaning Solution
185 R$
Unlimited Immunity
155 R$
Unlimited Energy
155 R$

Game passes for sale and their prices, measured from the Roblox passes API. Developer products bought inside the game aren’t publicly listable.